These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 25564572)
21. ICAM-1-Related Noncoding RNA in Cancer Stem Cells Maintains ICAM-1 Expression in Hepatocellular Carcinoma. Guo W; Liu S; Cheng Y; Lu L; Shi J; Xu G; Li N; Cheng K; Wu M; Cheng S; Liu S Clin Cancer Res; 2016 Apr; 22(8):2041-50. PubMed ID: 26667486 [TBL] [Abstract][Full Text] [Related]
22. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma. Cheung PF; Cheung TT; Yip CW; Ng LW; Fung SW; Lo CM; Fan ST; Cheung ST Oncotarget; 2016 Apr; 7(16):21644-57. PubMed ID: 26942873 [TBL] [Abstract][Full Text] [Related]
23. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines. Lirdprapamongkol K; Chiablaem K; Sila-Asna M; Surarit R; Bunyaratvej A; Svasti J Biochem Biophys Res Commun; 2012 Jun; 422(3):429-35. PubMed ID: 22580004 [TBL] [Abstract][Full Text] [Related]
24. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma. Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295 [TBL] [Abstract][Full Text] [Related]
25. Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma. Kim YR; Byun MR; Choi JW Cancer Biomark; 2018; 23(1):135-144. PubMed ID: 30010110 [TBL] [Abstract][Full Text] [Related]
26. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection. Fan H; Cui Z; Zhang H; Mani SK; Diab A; Lefrancois L; Fares N; Merle P; Andrisani O Oncogene; 2017 Apr; 36(17):2435-2445. PubMed ID: 27797380 [TBL] [Abstract][Full Text] [Related]
27. Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma. Gong SJ; Feng XJ; Song WH; Chen JM; Wang SM; Xing DJ; Zhu MH; Zhang SH; Xu AM Cancer Biol Ther; 2016; 17(2):151-62. PubMed ID: 26618405 [TBL] [Abstract][Full Text] [Related]
28. The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection. Zhao RC; Zhou J; Chen KF; Gong J; Liu J; He JY; Guan P; Li B; Qin Y Neoplasma; 2016; 63(2):288-98. PubMed ID: 26674131 [TBL] [Abstract][Full Text] [Related]
29. Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma. Jiang L; Shan J; Shen J; Wang Y; Yan P; Liu L; Zhao W; Xu Y; Zhu W; Su L; Chen J; Cheng F; Yao H; Xu H; Qian C; Liang Z Oncotarget; 2016 Jun; 7(24):36814-36828. PubMed ID: 27167111 [TBL] [Abstract][Full Text] [Related]
30. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells. Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424 [TBL] [Abstract][Full Text] [Related]
31. Expression and prognostic significance of Oct4 and Nanog in neuroblastoma. Monajemzadeh M; Soleimani V; Vasei M; Koochakzadeh L; Karbakhsh M APMIS; 2014 Sep; 122(9):734-41. PubMed ID: 24320714 [TBL] [Abstract][Full Text] [Related]
32. Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis. Liu M; Du L; He Z; Yan L; Shi Y; Shang J; Tang H Biomed Res Int; 2017; 2017():1252647. PubMed ID: 28373975 [No Abstract] [Full Text] [Related]
33. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
34. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related]
35. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA. Zhu C; Song H; Shen B; Wu L; Liu F; Liu X Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172 [TBL] [Abstract][Full Text] [Related]
36. SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma. Zhang X; You Q; Zhang X; Chen X Int J Mol Sci; 2015 Sep; 16(9):22662-75. PubMed ID: 26393582 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma. Lai KP; Chen J; He M; Ching AK; Lau C; Lai PB; To KF; Wong N Int J Cancer; 2014 Oct; 135(8):1790-9. PubMed ID: 24585547 [TBL] [Abstract][Full Text] [Related]
38. Correction: Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression. Clin Cancer Res; 2016 Dec; 22(24):6303. PubMed ID: 27980027 [No Abstract] [Full Text] [Related]
39. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Lu Y; Zhu H; Shan H; Lu J; Chang X; Li X; Lu J; Fan X; Zhu S; Wang Y; Guo Q; Wang L; Huang Y; Zhu M; Wang Z Cancer Lett; 2013 Oct; 340(1):113-23. PubMed ID: 23872274 [TBL] [Abstract][Full Text] [Related]